ADP101

· Alladapt Immunotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADP101, covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults [Phase 1, Phase 2]